Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Provencio-pulla, M.
~ 100  Ergebnisse:
Personensuche X
?
1

P2.31-12 Sexual Dysfunction on Patients with Lung Cancer: R..:

Ospina Serrano, A.V. ; Calvo, V. ; Collazo-Lorduy, A....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S412 , 2023
Link: https://doi.org/10.1016/..
 
?
2

P1.15-09 First-line Atezolizumab plus Bevacizumab for Metas..:

Provencio-pulla, M. ; Ortega, A.L. ; Coves, J....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S123-S124 , 2022
Link: https://doi.org/10.1016/..
 
?
3

12P Atezolizumab plus bevacizumab and chemotherapy in EGFR-..:

Frueh, M. ; Soo, R.A. ; Vervita, A....
ESMO Open.  9 (2024)  - p. 102591 , 2024
Link: https://doi.org/10.1016/..
 
?
4

138P Faecalibacterium prausnitzii enhances tumor response t..:

Rodriguez-Festa, A. ; Serna-Blasco, R. ; Nadal, E....
ESMO Open.  9 (2024)  - p. 102725 , 2024
Link: https://doi.org/10.1016/..
 
?
5

EP17.01-02 Data Mining to Build Metrics. A Feasible Assessm..:

Sánchez González, J.C. ; Nuñez Garcia, B. ; Blanco Clemente, M....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S734-S735 , 2023
Link: https://doi.org/10.1016/..
 
?
6

EP11.03-18 Optimal Duration of Immune Checkpoint Inhbitors ..:

Blanco Clemente, M. ; Collazo-Lorduy, A. ; Calvo de Juan, V....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S627-S628 , 2023
Link: https://doi.org/10.1016/..
 
?
7

LENALIDOMIDE PLUS R‐GDP (R2‐GDP) IN RELAPSED/REFRACTORY DIF..:

de la Cruz‐Merino, L. ; Martín García‐Sancho, A. ; Nogales Fernández, E....
Hematological Oncology.  37 (2019)  S2 - p. 258-259 , 2019
Link: https://doi.org/10.1002/..
 
?
8

SEOM clinical guidelines for the treatment of follicular no..:

Provencio Pulla, M. ; Alfaro Lizaso, J. ; de la Cruz Merino, L....
Clinical and Translational Oncology.  17 (2015)  12 - p. 1014-1019 , 2015
Link: https://doi.org/10.1007/..
 
?
9

SEOM clinical guidelines for the treatment of Hodgkin's lym..:

Rueda Domínguez, A. ; Alfaro Lizaso, J. ; de la Cruz Merino, L....
Clinical and Translational Oncology.  17 (2015)  12 - p. 1005-1013 , 2015
Link: https://doi.org/10.1007/..
 
?
10

249P Analysis of clinical and prognostic characteristics of..:

Cutillas, M. Martinez ; Sánchez, A. González ; Díaz, Y. Garitaonaindía...
ESMO Open.  9 (2024)  - p. 102711 , 2024
Link: https://doi.org/10.1016/..
 
?
11

LBA2 Clinical outcomes with perioperative nivolumab (NIVO) ..:

Awad, M. ; Cascone, T. ; Spicer, J....
ESMO Open.  9 (2024)  - p. 102985 , 2024
Link: https://doi.org/10.1016/..
 
?
12

252P Characterization of sexual dysfunction in women with l..:

Serrano, A.V. Ospina ; Calvo de Juan, V. ; Lorduy, A. Collazo...
ESMO Open.  9 (2024)  - p. 102714 , 2024
Link: https://doi.org/10.1016/..
 
?
13

214TiP Tarlatamab after chemoradiotherapy in limited-stage ..:

Hummel, H-D. ; Paz-Ares, L. ; Blackhall, F....
ESMO Open.  9 (2024)  - p. 102787 , 2024
Link: https://doi.org/10.1016/..
 
?
14

121P Health-related quality of life (HRQoL) outcomes from C..:

Spicer, J. ; Pulla, M. Provencio ; Awad, M....
ESMO Open.  9 (2024)  - p. 102700 , 2024
Link: https://doi.org/10.1016/..
 
?
15

251P Sexual dysfunction in patients with lung cancer: Inter..:

Serrano, A.V. Ospina ; Sentís, P. Guillén ; Azkona, E....
ESMO Open.  9 (2024)  - p. 102713 , 2024
Link: https://doi.org/10.1016/..
 
1-15